ENX-2 inhibitors represent a class of chemical compounds specifically designed to target and modulate the activity of the enzyme ENX-2, also known as Eukaryotic Nucleosome-Remodeling Factor 2. ENX-2 is a crucial component in chromatin remodeling, playing a pivotal role in the dynamic regulation of gene expression and chromosomal architecture. This class of inhibitors is characterized by their ability to selectively bind to the active site of ENX-2, thereby hindering its catalytic function. The inhibition of ENX-2 is of particular interest in the field of molecular biology and biochemistry, as it allows researchers to gain insights into the intricate mechanisms governing chromatin dynamics and epigenetic regulation.
ENX-2 inhibitors often feature a pharmacophore tailored to interact with the catalytic pocket of the enzyme, disrupting its enzymatic activity without interfering with other cellular processes. The design of these inhibitors is guided by a deep understanding of the three-dimensional structure of ENX-2 and the identification of key residues involved in its substrate recognition and catalysis. By selectively modulating ENX-2 activity, these inhibitors enable the manipulation of chromatin structure, offering a powerful tool for studying gene expression patterns and unraveling the complex interplay between chromatin remodeling and various cellular processes
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
A selective inhibitor of EZH2, which can also reduce EZH1 activity due to the structural and functional similarities between EZH1 and EZH2. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A dual inhibitor of EZH1 and EZH2, it binds to the SET domain of these enzymes, preventing their histone methyltransferase activity. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Primarily an EZH2 inhibitor, it can inhibit EZH1 to a lesser extent, leading to reduced methylation of histone H3 on lysine 27 (H3K27). | ||||||